Cécile Vassal
Institute Cancer De La Loire Lucien Neuwirth(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → Hyponatremia and Renal Sodium Wasting in patients receiving cisplatinum(1987)30 cited
- → Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study(2018)20 cited
- → Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)(2021)13 cited
- → Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d’Etude des Tumeurs Uro-Génitales)(2021)9 cited
- → Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach(2018)7 cited
- → Previous enzalutamide therapy and response to subsequent taxane therapy in metastatic castration-resistant prostate cancer.(2015)6 cited
- → PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort(2024)6 cited
- → Second-generation hormonotherapy in prostate cancer and bone microenvironment(2021)5 cited
- → Denosumab in patients with bone metastases from renal-cell carcinoma treated with anti-angiogenic therapy: a retrospective study from the GETUG (Groupe Etude des Tumeurs Uro Genitales)(2016)4 cited
- → Leptomeningeal Metastases in Renal Cell Carcinoma at Initial Diagnosis: 2 Case Reports and Literature Review(2019)3 cited